News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
Advanced Analytics Drives Innovation in Pharmacovigilance Risk Management Systems
In addition to case processing, AI is now being put to work in pharmacovigilance (PV) to identify adverse events from real-world data (RWD) sources such as social media, literature, and call center records, to manage high-risk populations, and for signal detection, tracking, and analysis.